Fr. 22.50

What kind of Provisions regulate the Access to ARV Medicine and how did Thailand react? - Seminar Paper

English · Paperback / Softback

Shipping usually within 2 to 3 weeks (title will be printed to order)

Description

Read more

Seminar paper from the year 2015 in the subject Medicine - Pharmacology, Pharmacy, grade: 2,0, , language: English, abstract: The Human Immunodeficiency Virus, short called HIV, targets the human immune system and weakens the surveillance and defense system against infections. Infected people become gradually immunodeficient, while the virus destroys and impairs the function of immune cells. The Immune function is typically measured by the CD4 cell count. The most advanced stage of HIV is the Acquired Immunodeficiency Syndrome (AIDS).HIV is a major public health issue, since it is the "world's most leading infectious killer" (WHO, 2014). Until today, no cure for HIV was found, but treatment with antiretroviral (ARV) drugs can help to control the virus. In a standard antiretroviral therapy (ART) are at least three antiretroviral drugs combatant to suppress the HIV virus and stop the progression of the disease. In 2013 around 12.9 million people are receiving ART globally, of which 11.7 million were in low- and middle-income countries.

Product details

Authors Anonym, Anonymous
Publisher Grin Verlag
 
Languages English
Product format Paperback / Softback
Released 31.07.2015
 
EAN 9783668021044
ISBN 978-3-668-02104-4
No. of pages 20
Dimensions 148 mm x 210 mm x 1 mm
Weight 45 g
Series Akademische Schriftenreihe Bd. V303796
Akademische Schriftenreihe Bd. V303796
Subject Natural sciences, medicine, IT, technology > Medicine > Pharmacy

Customer reviews

No reviews have been written for this item yet. Write the first review and be helpful to other users when they decide on a purchase.

Write a review

Thumbs up or thumbs down? Write your own review.

For messages to CeDe.ch please use the contact form.

The input fields marked * are obligatory

By submitting this form you agree to our data privacy statement.